The inactivation and excretion of many lipidsoluble compounds is a result of metabolic transformation to more polar substances (1) . For cortisol,1 this is sequentially accomplished in man by reduction of the 4,5 double bond in ring A to yield "dihydro" derivatives, then reduction of the ketone group at carbon three to yield "tetrahydro" compounds (2) . Reduction of the C-20 ketone group to a hydroxyl leads to further increase in polarity (3) . Once formed, these reduced compounds are rendered still more water-soluble by conjugation at the three position with glucuronic acid (1, 4) . The formation of such glucuronosides also results in a lesser degree of binding to plasma proteins (5, 6) .
The conjugation of a substrate with glucuronic acid in ester or glycosidic linkage requires uridine *Submitted for publication October 9, 1963 ; accepted June 22, 1964 .
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diphosphate-glucuronic acid (UDPGA) and the microsomal enzyme, uridine diphosphate (UDP)-transglucuronylase (7) . These requirements were demonstrated for a reduced steroid by Isselbacher and Axelrod (8, 9) , who isolated tetrahydrocortisone glucuronoside after incubation of THE and UDPGA with guinea pig liver microsomes.
Bilirubin also requires conjugation with glucuronic acid for its normal excretion into the bile (10, 11) . In children with the Crigler-Naj jar syndrome (12) , extreme retention of unconjugated bilirubin with kernicterus, two studies of steroid metabolism (13, 14) have shown a delay in the formation of THE-glucuronoside after the intravenous administration of THE. Although ability to form this steroidal glucuronoside was not entirely abolished, its total synthesis was decreased.
In 1957, Arias and London (15) showed that hepatic deficiency of UDP-transglucuronylase accounted for certain instances of mild jaundice associated with chronic retention of unconjugated bilirubin in adults. Further studies have confirmed this conclusion (16) . The present investigation was undertaken to elucidate the qualitative and quantitative aspects of steroid glucuro-conjugation in these patients and in others with familial and acquired jaundice.
Methods
Patients. Twelve healthy, ambulatory adults, 6 female and 6 male, served as controls for measurement of the disappearance rate of steroids from plasma. Three of these subjects were further studied for their urinary excretion of steroids. Two patients with untreated Addison's disease were studied in order to discover whether prolonged absence of steroid substrate brings about abnormalities in hepatic enzymes concerned with steroid metabolism. Neither of these individuals had ever been jaundiced. Four (17) made up the group with familial jaundice (Table  I) .2 Except for elevated levels of serum bilirubin, studies of hepatic function yielded normal results in all of these patients. Only the two patients with DubinJohnson syndrome demonstrated retention of sulfobromophthalein. By light microscopy, liver biopsy specimens obtained from five of the six patients were normal except for the finding of the characteristic pigment in the parenchymal liver cells of the patients with DubinJohnson syndrome. Further clinical data concerning these subjects are summarized in Table I . One patient with a past history of both acute viral hepatitis and hepatitis associated with infectious mononucleosis who was later found to have unconjugated hyperbilirubinemia and two patients with LaEnnec's cirrhosis were also studied; pertinent data are presented in Table II . The patients with hepatic diseases other than UDP-transglucuronylase deficiency were studied to determine whether the lesion present in the latter group was specific.
Administration of steroids. Crystalline tetrahydrocortisone,3 75 mg and 225 mg, was dissolved in 5 ml of hot distilled 95% ethanol and added to an infusion bottle containing 100 ml of warm, sterile, normal saline. To insure complete transfer, the beaker used for dissolving the steroid was rinsed 3 times with 2 ml of hot ethanol, and the rinses were added to the saline. Cortisol was drained directly from a vial containing 100 mg of cortisol in alcoholic solution into an infusion bottle containing 100 ml of normal sterile saline and used without further manipulation for intravenous administration. In one patient with UDP transglucuronylase deficiency and in the patient with a past history of hepatitis, an attempt was made to inhibit the glucuroconjugation of administered steroid by the simultaneous oral administration of a compound (menthol) that is also normally excreted in large part as a glucuronoside (1, 16) .
The THE injected and the steroid standards, THE, THF, and cortisol used in subsequent analyses were tested for purity. The compounds gave single spots by blue tetrazolium staining or ultraviolet absorption and had typical Rf values when chromatographed in the Bush B5 (20) and E2B (21) systems. They also gave infrared spectra4 identical to authentic standards. 2 We are indebted to Dr. Irwin Arias, Department of Medicine, Albert Einstein College of Medicine, for referring the patients with hepatic glucuronyl transf erase deficiency and the Dubin-Johnson syndrome to us for study. His permission to use the data collected by him in this paper and his unfailing co-operation are deeply appreciated. 3 We express our gratitude to Dr. Karl Pfister of Merck and Co., Rahway, N. J., for the generous supply of tetrahydrocortisone, tetrahydrocortisol, and cortisol. 4 Mr. Otto Gonzales kindly carried out the analyses in the laboratory of Dr. Seymour Lieberman. Rate of disappearance of steroids from plasma. Solutions containing steroids were given within 15 minutes after mixing; solutions were rapidly infused into an antecubital vein of all subjects immediately after the removal of 15 ml of blood that was used for the determination of basal plasma level of cortisol. All infusions were begun between 9 and 10 a.m. and were completed in 5 to 8 minutes. The mid-point of infusion was used as zero time. After administration of THE, venous blood was obtained by repeated venipuncture or indwelling needle at 20, 30, 45, and 60 minutes from zero time; for cortisol, the time schedule was 45, 60, 90, and 120 minutes. Samples were immediately transferred to heparinized tubes and centrifuged within 30 minutes. Plasmas not assayed immediately were quickly frozen and stored at -200 C until used. Two-or 3-ml samples of plasma were used for the determination of plasma 17-hydroxycorticosteroid level by the Silber-Porter method (22) , as modified by Peterson, Karrer, and Guerra (23) and in this laboratory (24) with cortisol as standard. Samples from any one experiment were tested simultaneously. Duplicate determinations were frequently made and showed a variability of less than 10%.
Disappearance rate from plasma was determined by plotting the four steroid values obtained against time on semilogarithmic paper. The best straight line through all points was found by applying the method of least squares. Plasma disappearance rate was then determined by extrapolating this line to the y-axis (zero time). The plasma disappearance rate is expressed as the biologic half-time (ti).5 For THE, the standard amount given was 75 mg; in a few instances 225 mg was given to provide a further overloading of hepatic detoxication mechanisms in an effort to detect subtle abnormalities.
Collection of urine. In all but two subjects, 24 -hour urine specimens were obtained before infusion of steroid. These were started between 7 and 9 a.m. and were usually collected in two 4-hour samples for the first 8 hours and in two 8-hour (25) were employed for the extraction and quantification of this steroid using added 4-C"-cortisol to correct for losses in extraction and paper chromatography. Determination of glucuronic acid conjugates in urine. The urine remaining after extraction was incubated at 37°C and pH 4.5 for 5 days with 3-glucuronidase,6 300 Fishman U per ml of urine. The urine was then extracted and processed as described above for the recovery of the free steroids. To assess the recovery of steroid after the hydrolysis, extraction, and washing and concentrating procedures, cortisol-4-C" of known specific activity was added to several samples of urine and treated in the same manner as the unknowns. Radioactivity was assayed in a liquid scintillation spectrometer; 7 efficiency for carbon" was 54%. Recovery of radioactivity from the urine so treated averaged 87%. No corrections for these losses have been made in the final calculations.
The term "glucuronoside" is used throughout to mean steroid measured after hydrolysis with ,B-glucuronidase.
Samples of the extracts were prepared for paper chromatography in such a way as to contain from 10 to 100
Ag of steroid. The samples were made from a solution of the concentrated extracts dissolved in dichloromethane: methanol, 2: 1, and were dried under a stream of nitrogen. Samples were concentrated in the bottom of each tube, dissolved in 4 drops of the dichloromethane: methanol mixture, and quantitatively applied with a polished capillary pipette, to 1-inch strips of Whatman 3MM chromatography paper by streaking along a narrow band penciled onto the paper. The greatest care was taken to distribute the sample evenly across the paper. Several rinses of the tube were applied to the chromatogram. With every four unknowns, two 1-inch strips containing 20-,ug amounts each of THE, THF, and cortisol were prepared in like manner. The chromatograms were equilibrated for 2 to 3 hours in the Bush B5 system and developed overnight for a total of 18 hours. After the strips were dried, at room temperature, they were viewed under ultraviolet light and then cut exactly in half. The left half of each strip was stained with an alkaline solution of blue tetrazolium and the THE, THF, and cortisol areas were identified by comparison with stained halves of the standard strips. Not infrequently, the urine samples ran at a somewhat slower rate than the standards, demonstrating the need to compare each unknown with itself to determine accurately the position of each steroid on the paper. Blue tetrazolium spots more polar (closer to the origin) than THF were not considered further in this experiment. Frequently, a seemingly discrete blue tetrazolium, Porter-Silber positive spot, running between THF and THE consistent with allo-THF was also seen. If this allo-THF area was rechromatographed separately in the Bush B5 or E2B systems, it usually showed the presence of some THE but no THF. The THF area remained homogenous on subsequent rechromatography, but the THE spot usually could be shown to contain allo-THF as a minor component. Apparently, after one chromatographic step in the Bush B5 system, with many hours of overrunning, THF can be cleanly separated from allo-THF if the paper is not overloaded with steroid. The separation of allo-THF from THE is less reliably achieved even when blue tetrazolium staining seems to indicate the presence of discrete spots. Since by our method of quantification, allo-THF is probably underestimated by 66% when THE is used as standard (26), the lower portion of any allo-THF spot seen was eluted along with the discernible THE area and subsequently treated as THE. Any error from this maneuver should be insignificant because after THE administration no interconversion to allo-THF is known to take place (27) , and the values for THE (contaminated with allo-THF) and THF in control urine samples have been subtracted from those observed after THE administration, a procedure that tends to cancel out completely the endogenous contribution' of allo-THF to the estimation of THE. This procedure also prevents the risk of losing THE by demarcating the THE area too sharply and arbitrarily from that of allo-THF.
The appropriate areas on the unstained standard and unknown strips were eluted by suspending one corner of each paper on a bent no. 22 hypodermic needle and allowing 10 ml of dichloromethane: methanol, 2: 1, to drip slowly through a syringe attached to the needle. When dry, the paper was rotated twice and eluted each time with 10 ml of solvent. This technique allowed quantitative elution of the steroids as determined by absence of blue tetrazolium staining on the eluted strips and absence of Porter-Silber chromogens in further exhaustive elutions. All the eluates were dried under nitrogen in a water bath at 370 C.
The dried eluates of the unknowns and standards and a blank tube were next shaken with 25 ml of dichloromethane and washed twice with 4 ml of 0.1 N NaOH. This washing procedure removed much chromogenic material. Two 10-ml samples of the dichloromethane extracts were next pipetted into a centrifuge tube of 15-ml capacity, which contained either 0.2 ml blank reagent (11.2 M H2SO4: redistilled absolute ethanol, 2:1) or 0.2 ml freshly prepared Porter-Silber reagent (75 ml blank reagent plus 32.5 mg recrystallized phenylhydrazine hydrochloride). These were shaken and centrifuged, and the solvent was removed carefully by aspiration. Maximal color was allowed to develop by incubating the tubes overnight in the dark at room temperature. Fifteen hours later, the blanks were read in a Beckman DU spectrophotometer at 410 myA; the tubes containing the reagent were also read at 370, 410, and 450 my as if applying the Allen correction (28). Only reagent readings that had sharp absorption maxima at 410 m1A were ac-1955 cepted as representing steroidal material. Blank readings at 410 my were usually much less than 25%o of the reagent reading at this wave length. The THF standard was used to quantify the THF unknowns because of the observed lesser chromogenicity of THF in the PorterSilber reaction (26, 29) . THE and cortisol standards were used to quantify THE and cortisol unknowns, respectively, although the latter two proved to be interchangeable (23, 26) . The quantity of steroid on each strip was calculated by reference to the optical density of the chromatographed standard. To obtain the content of steroid in the original extracts, the steroid content on paper was multiplied by the dilution factor of the sample.
This procedure for quantification automatically corrects all systematic losses, since the standards were handled in the same manner as the unknowns. By running a separate cortisol standard through the PorterSilber reaction simultaneously with each cortisol standard eluted off paper, it was determined that an average loss of 15% (range, 0 to 30%) was incurred during the various paper chromatographic steps. For THE, the reproducibility of the method determined by running many duplicate samples averaged 15%; for THF, it averaged 20%. Any value that appeared abnormal compared to the findings in normal subjects was rechecked. If (Table IV) .
In all instances, increased quantities of THF were recovered after the administration of THE. Values of THF ranged from 3.0 to 8.5% of the total steroid recovered in a 24-hour urine sample. (These data are recorded for the first 4 hours of the collection period in Table V .) The interconversion of THE to THF was quite rapid; increased quantities of THF were excreted within the first hour (Table V) . The process of interconversion continued, however, throughout the 24-hour period. Most of the urinary THE appeared as the glucuronoside. In FX, no greater quantity of THF was formed in the first 4 hours after 225 mg of THE than after the lesser dose, although the excretion of THE approximately tripled (Table V) . By the end of 24 hours, THF excretion was 1.65 times greater after the threefold larger dose of THE than after the lesser load, whereas THE excretion was 3.86 times greater.
Patients with familial jaundice. After both 75 mg and 225 mg THE, the recovery of this steroid as urinary THE and THF over 24 hours was within the normal range (Table IV No abnormalities in the metabolism of THE were noted in the patients with the Dubin-Johnson syndrome or in the patient with hemolytic jaundice (Table IV) .
Fractional excretion of urinary metabolites after THE infusion Normal subjects. In the three normal subjects, most of the recovered THE and THF, free and conjugated, appeared in the urine in the first 4 hours after infusion of 75 mg of THE (67.5 to 85.0%, fable IV). Seventy-five and six-tenths per cent of the metabolites recovered after the 225 mg dose was excreted by FX in the first 4 hours (Table V) . Table V and Figure 1 show that most of the urinary THE and THF appeared in the first hour following injection of THE, regardless of the size of the dose. There was a somewhat greater delay in the appearance of THF than of THE (Table V) . Patients zeith familial jaundice. In the first 4 hours after infusion of THE, 75 mg and 225 mg, the patients with UDP-transglucuronylase deficiency excreted from 56.6 to 80.5% of the THE and THF eventually recovered in the urine by the end of 24 hours (Table IV) . With the possible exception of MB (56.6%o excretion in the first 4 hours), these results are similar to those found in the normal subjects (67.5 to 85.0%o). The first time GC was studied when the plasma t4 for the injected THE was prolonged, urine was collected at 8-hour intervals only. To detect early abnormalities in THE metabolism, urine was collected thereafter in 1-hour samples for the first Figure 1 ) clearly show that there was a significant delay in the excretion of THE, a lesser amount of the steroid appearing in the first hour and a greater amount in the second hour than in the normal subjects. This phenomenon occurred at both dosage levels of THE. When GC received oral menthol before the injection of 75 mg THE, the per cent THE and THF excreted within the first and second hours returned to the normal pattern (Table V, Figure  2 ). Menthol conjugation remained impaired, the value being less than 50% of normal, a value essentially the same as that obtained when menthol was administered alone (Table I ). This experiment is to be compared with that done in subject GA with a past history of viral hepatitis (see below).
The pattern of excretion of THF in the patients with familial jaundice followed that shown by the normal subjects (Table V) (Table IV) . In these two patients, urine was not collected at hourly intervals. RM, the patient with compensated hemolytic anemia metabolized THE normally (Tables IV and V (Table IV) . Of this, 4.2% was THF and only 0.4% was unconjugated (Table IV) . In the first 4 hours after infusion, 63.8% of the recovered dose appeared (Table IV) , a normal amount, but only 36.6% of this was excreted within the first hour, whereas 32 .2% appeared in the second hour (Table V, Figure 1 ). This pattern is almost identical to that shown by GC (glucuronyl-transferase deficiency). Moreover, when oral menthol was ingested 2 hours before injection of THE, the THE and THF excreted within the first hour increased by 11.9%1o and that excreted in the second hour de- creased by 4.4% (Table V, Figure 2 ), the total recovery at the end of 4 hours remaining unchanged (Table V) .
JS (fatty infiltration and cellular necrosis) excreted 63.9% of administered THE as THE and THF in 24 hours (Table IV) . Eighty-four per cent of the total 24-hour urinary excretion took place within the first 4 hours (Table IV) , and 48.5% of that appeared within the first hour. Unconjugated THE and THF accounted for only 1.3% of the total recovered steroid (Table IV) (Table IV) , again an abnormally low proportion. Thirty-two and four-tenths per cent of the first 4-hour excretion appeared in the first hour. Interconversion of THE to THF appeared to be unimpaired in this patient.
Addison's disease. The 24-hour recovery of THE and THF was normal in both patients, although JC appeared to excrete 3.3% 8 of the administered THE (75 mg) as unconjugated steroid, a somewhat elevated value (Table IV) .
In FG there was a delay in the excretion of metabolites as evidenced by a lesser per cent of re- 8 This high percentage of free steroid may be accounted for by the fact that the sample collected from hours 9 to 16 in this patient was lost (Table IV) . A loss of steroid at this time with no loss during the first 4 hours, the period in which virtually all of the unconjugated metabolites appear, could easily result in a distortion of the true state of glucuroconj ugation. For the same reasons, the figure of 66.8% for recovery of THE and THF in the first 4 hours (Table IV) is somewhat higher than it should be. (Table IV) and a greater per cent recovered in the second 8 hours than in any other patient. In neither patients JC nor FG did interconversion of THE to THF exceed the normal limits.
Metabolism of cortisol
All of the normal subjects except FX, and patients GC, AL, DA, JS, MF, and GA received 100 mg of cortisol. The excretion of urinary metabolites was studied in the same manner as for the THE experiments and included the collection of urine at hourly intervals for the first 4 hours. Although the appearance of THE and THF in the urine followed an entirely different pattern from that following THE, the only patient who showed deviation from the normal was MF (hepatic cirrhosis). In this patient total 24-hour recovery of steroid was reduced and its appearance in urine was delayed markedly.
Discussion
Metabolism of tetrahydrocortisone in normal subjects. The studies of normal subjects show that THE is rapidly conjugated with glucuronic acid and that the urinary excretion of this glucuronoside is also prompt. Within the limits tested, the dosage of administered THE does not appreciably influence its rate of metabolism. For cortisol, the rate of disappearance is slower after a pharmacologic dose than after a trace amount of radioactively labeled hormone (30) . Although plasma disappearance rate of a trace quantity of THE has not been measured, Rappaport and Migeon (31) reported an average of 1.95% of nonconjugated radioactive label in urine of normal subjects after intravenous infusion of 4-C14-THF, a per cent comparable to that reported here for excretion of unconjugated THE and THF after much larger quantities of THE.
The metabolism of THF may not be entirely comparable to that of THE. The rate of appearance of THF glucuronoside was slower than that for THE, indicating that THF may be conjugated more slowly (data not shown here).
The recovery of THF after the injection of THE confirms the work of several authors concerning the interconversion of these two steroids (27, 32, 33) . This transformation occurs rapidly (27) . In the present study, increased amounts of THF were always recovered within the first hour after infusion of THE. C-20-reduced steroids, e.g., /3-cortolone, were not specifically sought; others have shown rapid conversion of THE to this group of compounds (27, 32, 33) . The capacity to convert THE to THF is, however, limited. Only slightly greater amounts of THF were recovered after administration of 225 mg of THE than after 75 mg. Steroid not recovered as urinary THE and THF after THE infusion was not identified in this investigation. In addition to C-20 hydroxylated derivatives, C-19, 11-oxygenated-17-ketosteroids are formed (2) . On the second occasion that patient GC received an infusion of 75 mg of THE, the 24-hour urinary excretion of 17-ketosteroids and 17-ketogenic steroids was measured and compared to control values: 40.5 mg of THE plus THF were isolated; the 17-ketogenic steroid excretion rose 42.2 mg. The closeness of these two figures indicates little, if any, significant conversion of THE to C-20 hydroxylated derivatives. 17-Ketosteroid excretion increased by 8.5 mg, a quantity representing only 11% of the administered THE, presumably converted to C-19 compounds. The fate of a significant portion (about one-third) of the administered THE thus remains unaccounted for.
Metabolism of tetrahydrocortisone in patients with familial jaundice. Evidence for delayed metabolism of THE was found in all three patients with UDP-transglucuronylase deficiency, but not in those with familial jaundice of other etiology. In MB, abnormal glucuroconjugation was shown by delay in plasma disappearance rate of THE. The small increase in per cent THE converted to THF may also have been the direct consequence of a slower rate of glucuronoside formation, more time being available for interconversion to proceed. The failure to find a greater than normal increase in unconjugated steroid in the urine in this patient may be attributable to renal insufficiency. MB suffered from chronic pyelonephritis (blood urea nitrogen, 49 mg per 100 ml) and congestive heart failure. It is unlikely that renal disease accounts for the prolonged tj of unconjugated THE, however, since marked prolongation of plasma disappearance rate of cortisol is not characteristic of renal failure (34) (36) . In the homozygous Gunn rat, an animal with genetic deficiency of enzymes responsible for glucuronic acid transfer (37, 38) , testosterone glucuronoside formation by everted intestinal sacs was impaired (39) . To explain why the defect in steroid glucuronoside formation was quantitatively less striking than for bilirubin and menthol in MB, GC, and AL, extrahepatic glucuroconjugation of steroid may be postulated. In vitro (40, 41) and in vivo (42, 43) experiments have demonstrated the capacity of kidney and gastrointestinal tract to carry out glucuronic acid conjugation. Alternatively, one may theorize that the affinity of the conjugating system for reduced steroid is greater than for the other substrates tested. In one experiment the rate of conjugation of THF was slower than that of THE, indicating that even small structural differences in substrates may be important. Other work has shown the importance of the 17a-hydroxyl group in this regard (44) . Another possible conclusion is that the enzyme system responsible for the glucuroconjugation of THE is different from the transferase necessary for bilirubin conjugation. In support of the idea that more than one glucuronic acid transferring enzyme may exist, Slaunwhite, Lichtman, and Sandberg (45) have demonstrated that glucuroconjugation at the 16 position of certain estrogenic hormones is accomplished in human liver by a system differing from that acting at the 3a-position, the usual site of conjugation (2) . Several investigators have also shown that N-linked glucuronosides are probably not dependent upon UDP-transglucuronylase (46, 47) .
Detectable impairment of THE conjugation was abolished in GC when 1 g of menthol was administered 2 hours before the steroid. Although the conjugating defect in GC was shown to be variable (see above), and it may be argued that this finding was merely coincidental, indirect hyperbilirubinemia was present at the time of study, and impairment of menthol tolerance was as severe as it had been months earlier. Furthermore, this study was done only 9 days after a similar investigation without menthol administration had shown delay in steroid glucuronoside formation. The ability of menthol to favor more rapid appearance of THE glucuronoside in the urine after THE infusion was also demonstrable in subject GA (prior history of viral hepatitis). Possibly then, menthol can enhance the glucuroconjugation of THE in man. Although stimulation of hepatic microsomal enzyme activity by drugs has not been previously reported to occur in human subjects, its occurrence in experimental animals has been amply demonstrated (48) (49) (50) (51) (52) . The apparent stimulation of THE conjugation by menthol in these experiments suggests that the transferase for THE glucuronoside formation may be distinct from that of menthol. Thus, the findings in the patients of this study cannot be attributed conclusively to a deficiency or a defect in a single conjugating enzyme.
Although others have postulated an abnormality in the hepatic uptake of substrate (53) in an unselected group with so-called "Gilbert's disease," this hypothesis does not fit the data of the present study. A defect in hepatic uptake of THE in our patients is most unlikely, since the conversion of THE to THF (an intracellular reaction) took place as readily and as rapidly in them as in the normal subjects. Although extrahepatic reduction of THE is, of course, a possible compensatory mechanism, its occurrence in man has not been demonstrated. The present observations in adult patients with UDP-transglucuronylase deficiency are not entirely similar to those in children with a more severe form of unconjugated hyperbilirubinemia, the Crigler-Naj jar syndrome (12) . Whereas both rate of conjugation and total synthesis of steroid conjugate were impaired in the latter, only the rate of glucuronoside formation was diminished in the former. Detailed analysis of cortisol metabolism after 100 mg of the hormone administered intravenously in the patients of this study failed to reveal any detectable abnormality. After cortisol-4-C14 was given to two children with the Crigler-Najjar syndrome, a subnormal quantity of injected radioactivity appeared in the urine in 24 hours as known metabolites [the majority of which should be C-21 glucuronosides (2) ], although total 24-hour urinary excretion of radioactivity appeared to be within the normal limits (13, 14) . With (THE) , the rate of reduced steroid conjugation with glucuronic acid was assessed by measuring the rate of its plasma disappearance and by analyzing urine collected at frequent intervals after infusion. These procedures yielded useful information concerning steroid metabolism provided renal function was normal.
2) In three adult patients with familial jaundice previously shown to have hepatic deficiency of the enzyme uridine diphosphate (UDP)-transglucuronylase, but not in other patients with familial jaundice of differing etiology, THE glucuronoside formation was delayed without appreciable impairment in total synthesis. Quantitatively, the lesion was not so severe for steroid as it was for bilirubin and menthol. The metabolism of cortisol was normal. A delay in THE glucuronoside formation was also found in one subject with unconjugated hyperbilirubinemia and a past history of viral hepatitis.
3) In one patient with UDP-transglucuronylase deficiency the defect in THE conjugation could not be detected after 1 g of menthol was administered 2 hours before a test dose of THE. In the patient with a past history of hepatitis the same dose of menthol also enhanced the rate of THE glucuronoside formation. This and other data suggest that the transferase for THE glu-curonoside formation may be distinct from that of menthol. 4) Two patients with severe hepatic insufficiency secondary to alcoholism but differing in their clinical and pathological findings were studied. One showed a severe disorder of both THE and cortisol metabolism, and the other did not. Thus patients with even marked impairment of liver function do not comprise a homogeneous group with respect to the disposition of steroid hormones.
5) In two patients with untreated Addison's disease, the metabolism of THE was essentially normal. Prolonged absence of normal amounts of substrate therefore does not affect the ability to metabolize it.
